In vitro cytological experiments demonstrated that this vector replicated and expressed Hsp70 at high level in Survivin-positive gastric cancer cells, but it expressed Hsp70 at low level in the normal cell lines, which showed that this therapeutic strategy yields targeted gene expression. The gene discussed is BIRC5; the disease is gastric cancer.